Results 11 to 20 of about 349,716 (299)
Tumor marker CA-125 in adnexal inflammatory tumors [PDF]
Background/Aim. The glycoprotein of a high molecular weight CA-125, which is not a specific tumor marker of ovarian cancer, is secreted by the endothelial cells of most pelvic organs. Endometriosis, inflammatory processes in the pelvic cavity, as well as
Nikolić Branka +2 more
doaj +1 more source
Performance of Ovarian Response Prediction Index As Predictor of Ovarian Response
Objective: We aimed to evaluate potential predictors of response to controlled ovarian stimulation (COS), including follicle stimulating hormone (FSH), Estradiol, antral follicle count (AFC), and ovarian response prediction index (ORPI). Methods: In this
Bolormaa Dagvadorj +5 more
doaj +1 more source
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access (R) OV Monitor assay on the UniCel (R) Dxl 800 Immunoassay System [PDF]
Background: Cancer antigen CA125 is known as a valuable marker for the management of ovarian cancer. Methods: The analytical and clinical performance of the Access OV Monitor Immunoassay System (Beckman Coulter) was evaluated at five different European ...
Anonymous +12 more
core +5 more sources
Ovarian Biomechanics: From Health to Disease
Biomechanics is a physical phenomenon which mainly related with deformation and movement of life forms. As a mechanical signal, it participates in the growth and development of many tissues and organs, including ovary.
Chenchen Sun +4 more
doaj +1 more source
Polycystic ovarian disease represents a poorly defined spectrum of clinical disorders having oligo-ovulation or anovulation as a common feature. There is no single, universally accepted biochemical or clinical definition. Clinical findings usually include anovulation resulting in irregular uterine bleeding and infertility, androgen excess resulting in ...
Z. N. Zakov, M. M. Quigley
+6 more sources
RUNX1-Regulated Signaling Pathways in Ovarian Cancer
Ovarian cancer is the leading cause of gynecological death worldwide, and its poor prognosis and high mortality seriously affect the life of ovarian cancer patients.
Yuanzhi Chen, Yingying He, Shubai Liu
doaj +1 more source
Objective: Apolipoprotein A1 (ApoA1) is remarkably decreased in serum and ovarian tissues of ovarian cancer patients. ApoA1 and ApoA1 mimetic peptides can sequestrate pro-inflammatory phospholipids, some of which are known to activate a variety of ...
Aline T. Marinho +8 more
doaj +1 more source
Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. [PDF]
The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker.
Anastasi, Emanuela +6 more
core +1 more source
Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Anastasi +39 more
core +1 more source
PREMATURE OVARIAN INSUFFICIENCY IN SYSTEMIC SCLEROSIS
The early onset of ovarian aging results in decreased ovarian reserve and premature ovarian insufficiency (POI), leading to infertility and early menopause. POI is associated with systemic autoimmune diseases.
Neslihan Gokcen
doaj +1 more source

